Viewing Study NCT01019161

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:47 AM
Ignite Modification Date: 2026-01-28 @ 12:25 PM
Study NCT ID: NCT01019161
Status: COMPLETED
Last Update Posted: 2010-10-20
First Post: 2009-11-23
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: An Open Label, Single Centre Mass Balance C14 Study in Patients With Acute Myeloid Leukaemia (AML)
Sponsor: AstraZeneca
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myeloid Leukaemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Acute Myeloid Leukaemia (AML) View
None AML View
None AZD1152 View
None Pharmacokinetics View